David M Mott Mersana Therapeutics, Inc. (MRSN) insider trading activity

MRSN Quotes by TradingView

David M Mott is Director of Mersana Therapeutics, Inc.. Currently has a direct ownership of 588,694 shares of MRSN, which is worth approximately $1.2 Million. The most recent transaction as insider was on Jan 02, 2024, when has been sold 8,810 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 589K
0% 3M change
1.52% 12M change
Total Value Held $1.2 Million

DAVID M MOTT Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 02 2024
BUY
Grant, award, or other acquisition
-
8,810 Added 1.47%
588,694 Common Stock
Oct 02 2023
BUY
Grant, award, or other acquisition
-
15,873 Added 2.66%
579,884 Common Stock
Jul 03 2023
BUY
Grant, award, or other acquisition
-
6,079 Added 1.07%
564,011 Common Stock
Jun 08 2023
BUY
Grant, award, or other acquisition
-
14,467 Added 2.53%
557,932 Common Stock
Apr 03 2023
BUY
Grant, award, or other acquisition
-
4,866 Added 0.89%
543,465 Common Stock

Also insider at

EPZM
Epizyme, Inc. Healthcare
Director
ARDX
ARDELYX, INC. Healthcare
Director
NVAX
NOVAVAX INC Healthcare
IMRA
IMARA Inc. Healthcare
Director
ADAP
Adaptimmune Therapeutics PLC Healthcare
Director
DMM

David M Mott

Director
Big Sky, MT

Track Institutional and Insider Activities on MRSN

Follow Mersana Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRSN shares.

Notify only if

Insider Trading

Get notified when an Mersana Therapeutics, Inc. insider buys or sells MRSN shares.

Notify only if

News

Receive news related to Mersana Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MRSN